Aluminum Hydroxide and Magnesium Trisilicate and Ramucirumab Intravenous
Determining the interaction of Aluminum Hydroxide and Magnesium Trisilicate and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aluminum hydroxide / magnesium trisilicate
Brand name: Drysol, Hypercare, Xerac AC, Gaviscon Tablet
Synonyms: n.a.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aluminum Hydroxide and Magnesium Trisilicate-Ranexa
- Aluminum Hydroxide and Magnesium Trisilicate-Ranibizumab
- Aluminum Hydroxide and Magnesium Trisilicate-Ranibizumab Intraocular
- Aluminum Hydroxide and Magnesium Trisilicate-Ranibizumab ophthalmic
- Aluminum Hydroxide and Magnesium Trisilicate-Ranitidine
- Aluminum Hydroxide and Magnesium Trisilicate-Ranitidine Capsule
- Ramucirumab Intravenous-Aluminum hydroxide, magnesium hydroxide, and simethicone
- Ramucirumab Intravenous-Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone Chewable Tablets
- Ramucirumab Intravenous-Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone Suspension
- Ramucirumab Intravenous-Alunbrig
- Ramucirumab Intravenous-Alupent
- Ramucirumab Intravenous-Alupent (Metaproterenol Syrup)